Skip to main content
. 2019 Apr;11(4):1589–1596. doi: 10.21037/jtd.2019.04.65

Table 2. Baseline characteristics of patients with AMI.

Characteristic Total (n=1,309) β-blockers (n=1,074) Non β-blockers (n=235) P value
Demographics
   Age (years) 61.5±12.1 60.7±11.9 65.3±12.4 <0.001
   Age <75 y, n (%) 194 (14.8) 139 (12.9) 55 (23.4) <0.001
   Female, n (%) 211 (16.1) 163 (15.2) 48 (20.4) 0.047
   Weight (kg) 64.8±10.7 65.3±10.8 62.7±10.0 0.001
   SBP (mmHg) 121.9±20.2 122.5±19.2 119.0±24.3 0.016
   DBP (mmHg) 73.5±11.9 74.2±11.5 70.5±13.6 <0.001
Medical history, n (%)
   DM 267 (20.4) 213 (19.8) 54 (23.0) 0.278
   Smoke 628 (48.0) 517 (48.1) 111 (47.2) 0.802
   Hypertension 650 (49.7) 525 (48.9) 125 (53.2) 0.231
   Hyperlipidemia 202 (15.4) 170 (15.8) 32 (13.6) 0.395
   History of CABG 2 (0.2) 2 (0.2) 0 (0.0) 0.508
Laboratory index
   eGFR (mL/min/1.73 m2) 80.7±26.5 82.4±26.0 72.7±27.3 <0.001
   SCr (μmol/L) 94.76 (35.5) 92.68 (33.8) 104.27 (41.2) <0.001
   LDL-c (mmol/L) 2.7±0.9 2.7±0.9 2.7±0.7 0.984
   Total cholesterol (mmol/L) 4.3±1.1 4.3±1.1 4.4±1.1 0.764
   LVEF (%) 53.8±10.9 54.0±10.9 52.9±11.2 0.167
   lgBNP 3.0±0.6 2.9±0.6 3.2±0.7 <0.001
   HbA1c (%) 6.5±1.5 6.5±1.5 6.6±1.5 0.377
   Anemia, n (%) 430 (32.8) 337 (31.4) 93 (39.6) 0.015
Perioperative medications, n (%)
   ACEI/ARB 1,168 (89.2) 1,000 (93.1) 168 (71.5) <0.001
   CCB 110 (8.4) 92 (8.6) 18 (7.7) 0.650
   Diuretic 403 (30.8) 321 (29.9) 82 (34.9) 0.132
Angiographic and procedural characteristics
   Emergent PCI, n (%) 693 (52.9) 547 (50.9) 146 (62.1) 0.002
   Peri-hypotension, n (%) 105 (8.0) 72 (6.7) 33 (14.0) <0.001
   Peri-IABP, n (%) 109 (8.3) 62 (5.8) 47 (20.0) <0.001
   Coronary lesions 2.1±1.0 2.1±1.0 2.2±1.0 0.058
   Contrast volume >200 mL, n (%) 82 (6.3) 66 (6.1) 16 (6.8) 0.704
   Total HV (mL) 877.7±557.6 844.0±524.8 1031.7±668.0 <0.001

SBP, systolic blood pressure; DBP, diastolic blood pressure; DM, diabetes mellitus; CABG, coronary artery bypass grafting; eGFR, effective glomerular filtration rate; SCr, serum creatinine rate; HDL-c, high density lipoprotein cholesterol; LDL-c, low density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; lgBNP, lg brain natriuretic peptide; HbA1c, hemoglobin A1c; ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor blocker; CCB, calcium channel blocker; LM, left main coronary artery; PCI, percutaneous coronary intervention; IABP, intra-aortic balloon pump; HV, hydration volume.